Delivery Order HHSN261201700007I-HHSN26100003

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $99,000 firm fixed price purchase order to Targetmol Chemicals Inc. to synthesize analogs of repsox and intermediates from two ongoing medicinal chemistry projects. Over a six-month period after receipt of order, Targetmol will synthesize the requested compounds and deliver milligram to gram quantities to NCATS along with electronic progress reports, analytical data including LCMS and 1H NMR, and...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Chiralix B.V., a for-profit organization, for $17,995.00. The contract is for custom synthesis of a depsipeptide and does not have a set-aside designation. The contract was awarded on April 15, 2016, with a completion date of July 8, 2016. Chiralix B.V. is the prime contractor, and there are no major subcontractors mentioned. The contract is not associated with a larger...

This is a $162,000 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for the synthesis of thyclotides and cyclopentane-constrained peptide nucleic acids. The award was made on a sole-source basis under simplified acquisition procedures, as Frontage was determined to be the only source capable of scaling up the production of these...

This is a cost-plus-fixed-fee delivery order task order awarded by the National Institutes of Health National Institute on Drug Abuse (NIH NIDA) to the non-profit research organization Research Triangle Institute (RTI) International. The $2,291,030.00 contract is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 9, 2018 to June 8, 2019. The contract does not have a set-aside designation. RTI has experience providing a range of...

Organix Chemistry Solutions LLC was awarded a $3.677 million delivery order against the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences' CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract. The delivery order, issued for the period of September 28, 2020 through September 27, 2022, provides synthetic chemistry support services to the TDB Medicinal Chemistry Team. Key services will involve...

This federal contract award was issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering to STA Pharmaceutical US LLC, a for-profit foreign-owned company. The $199,058.00 firm-fixed-price purchase order is for the delivery of 20 grams of EB-CPT under good manufacturing practice (GMP) conditions. The award is associated with a pre-solicitation opportunity posted on August 8, 2019, with a due...

This firm-fixed-price purchase order was awarded by the Office of Naval Research (ONR), a Defense agency, to Strem Chemicals Inc., a for-profit chemical manufacturing company, for the delivery of trimethylaluminum, an electronic-grade chemical. The $30,032.00 contract has a period of performance through November 1, 2023 and does not utilize any set-aside designation. Strem Chemicals, which has been registered in the System for Award Management (SAM) since 2001, has previously provided various...

This contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (HHS-NIH-NIDA) to Research Triangle Institute - doing business as R T I International is for the synthesis and distribution of drugs of abuse and related compounds from June 9, 2023 to June 8, 2024 under Task Order 75N95023F00001 (TO4) of major program N01DA-22-8944. The contract type is a delivery order with a place of performance in Research Triangle Park, North...

This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to On Demand Pharmaceuticals Inc. The contract is for the development of small manufacturing systems to produce research-grade pharmaceutical intermediates, under SBIR Topic 024. The contract is a firm-fixed-price definitive contract with a ceiling value of $325,000.00 and an ultimate completion date...